[Studies on the syntheses of sulfur containing pyrimido [5,4-d]pyrimidine derivatives. III. A new synthesis of dipyridamole]. 1976

K Imai, and N Inukai, and T Ishida, and T Ozasa, and S Kawahara

UI MeSH Term Description Entries
D008722 Methods A series of steps taken in order to conduct research. Techniques,Methodological Studies,Methodological Study,Procedures,Studies, Methodological,Study, Methodological,Method,Procedure,Technique
D004176 Dipyridamole A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752) Antistenocardin,Apo-Dipyridamole,Cerebrovase,Cléridium,Curantil,Curantyl,Dipyramidole,Kurantil,Miosen,Novo-Dipiradol,Persantin,Persantine,Apo Dipyridamole,Novo Dipiradol

Related Publications

K Imai, and N Inukai, and T Ishida, and T Ozasa, and S Kawahara
May 1976, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
K Imai, and N Inukai, and T Ishida, and T Ozasa, and S Kawahara
May 1976, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
K Imai, and N Inukai, and T Ishida, and T Ozasa, and S Kawahara
July 1972, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
K Imai, and N Inukai, and T Ishida, and T Ozasa, and S Kawahara
January 1989, Archivum immunologiae et therapiae experimentalis,
K Imai, and N Inukai, and T Ishida, and T Ozasa, and S Kawahara
September 1962, Bollettino chimico farmaceutico,
K Imai, and N Inukai, and T Ishida, and T Ozasa, and S Kawahara
September 1994, Die Pharmazie,
K Imai, and N Inukai, and T Ishida, and T Ozasa, and S Kawahara
June 1973, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
K Imai, and N Inukai, and T Ishida, and T Ozasa, and S Kawahara
May 1990, Biomedical chromatography : BMC,
K Imai, and N Inukai, and T Ishida, and T Ozasa, and S Kawahara
August 2020, Molecules (Basel, Switzerland),
Copied contents to your clipboard!